You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

"Ionis"
Topics

Advertisement

"Ionis"

Showing articles that match "Ionis" in the headline

In the last 6 hours

AstraZeneca, Ionis drug fails big heart disease study in major setback BioPharma Dive 13:40

Ionis, AstraZeneca Pivotal Heart Disease Drug Flunks Benzinga 13:15

Levi Strauss, Ionis Pharmaceuticals, Gloo Holdings And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session Benzinga 13:08

Advertisement

Advertisement

In the last 8 hours

AZ, Ionis hit by unexpected Wainua trial failure pharmaphorum 10:48

Earlier Today

Stock Market Today: S&P 500, Nasdaq 100 Futures Rise as US-Iran Exchange Strikes—Levi Strauss, Azz, Ionis Pharma In Focus Benzinga 10:23

STAT Plus: AstraZeneca, Ionis report major trial failure with heart disease drug STAT 10:16

Ionis And AstraZeneca's Cardio-TTRansform Trial Of Eplontersen In Attr-Cm Misses Primary Endpoint RTT News 09:45

AstraZeneca shares slide after Ionis-partnered drug fails late-stage heart disease trial The Times of India 09:25

Tuesday

Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment Hospital Management 11:06 Tue, 07 Jul

Monday

Ionis completes enrollment in pivotal cohort of the Phase 3 reveal study evaluating obudanersen in Angelman syndrome Business Wire (Press Release) 12:06 Mon, 06 Jul

In the last month

Ionis Inks Zilganersen Pact With Recordati To Zero In On US Scrip Pharma Intelligence 12:33 Fri, 26 Jun

Ionis grants Recordati rights to zilganersen for Alexander disease Hospital Management 10:45 Fri, 26 Jun

Ionis wins wider Tryngolza approval for hypertriglyceridemia BioWorld 21:51 Thu, 25 Jun

Ionis' Tryngolza claims critical label expansion in US pharmaphorum 10:48 Thu, 25 Jun

Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S. Business Wire (Press Release) 08:05 Thu, 25 Jun

Advertisement

Ionis’ Evolution Takes Root With Tryngolza Expansion Into sHTG Scrip Pharma Intelligence 21:12 Wed, 24 Jun

How Olezarsen’s Longer-Term Hepatic Data and High Retention Could Shape Ionis Pharmaceuticals (IONS) Investors Simply Wall St 04:02 Sat, 20 Jun

Ionis Adds Biopharma Veteran Ludwig Hantson As Commercial Phase Nears Simply Wall St 14:26 Thu, 11 Jun

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Climate Crisis
UK UK
World World
Business Business
Entertainment
Sport Sport
Football Football
Technology Technology
Science Science
Lifestyle Lifestyle
Industry Sectors